VERV - Why Verve Therapeutics Stock (VERV) Is Falling | Benzinga
Verve Therapeutics Inc (NASDAQ: VERV) shares are trading lower by 6.3% to $11.18 Wednesday morning after the company priced its proposed public offering of common stock and concurrent private placement.
What Investors Should Know
Verve is conducting a two-part fundraising effort. They're planning a public offering and a simultaneous private sale ...
VERV) Is Falling>Full story available on Benzinga.com